User:Kaitlyn Enderle/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 15: | Line 15: | ||
<scene name='75/752351/Hbond_leu29/3'>hydrogen bond</scene> | <scene name='75/752351/Hbond_leu29/3'>hydrogen bond</scene> | ||
| + | |||
| + | |||
| + | |||
| + | |||
| Line 38: | Line 42: | ||
<scene name='75/752351/Ddah_water_pore/3'>water pore</scene> | <scene name='75/752351/Ddah_water_pore/3'>water pore</scene> | ||
| - | <scene name='75/752351/Ddah_active_site/1'>active site</scene> | ||
<scene name='75/752351/Ddah_active_site_his162/1'>His162</scene> | <scene name='75/752351/Ddah_active_site_his162/1'>His162</scene> | ||
| Line 46: | Line 49: | ||
2. <scene name='75/752351/Ddah_water_pore/7'>His172 and Ser175</scene> | 2. <scene name='75/752351/Ddah_water_pore/7'>His172 and Ser175</scene> | ||
| - | <scene name='75/752351/Hbond_leu29/1'>hydrogen bond</scene> | ||
| - | |||
| - | |||
| - | == Function == | ||
DDAH in complex with <scene name='75/752351/Ddah_with_l-citrulline/3'>L-citrulline</scene> | DDAH in complex with <scene name='75/752351/Ddah_with_l-citrulline/3'>L-citrulline</scene> | ||
| - | |||
| - | == Disease == | ||
| - | |||
| - | == Relevance == | ||
| - | DDAH works to hydrolyze MMA and ADMA. Both MMA and ADMA competitively inhibit NO synthesis by inhibiting Nitric Oxide Synthase (NOS). Because NO is highly toxic, freely diffusible across membranes, and its radical form is fairly reactive, cells must maintain a large control on concentrations by regulating NOS activity and the activity of enzymes such as DDAH that have an indirect effect of the concentration of NO. An imbalance of NO contributes to several diseases. Low NO levels, potentially caused by low DDAH activity and therefore high MMA and ADMA concentrations, have been implicated with diseases such as uremia, chronic heart failure, atherosclerosis, and hyperhomocysteinemia. High levels of NO have been involved with diseases such as septic shock, migraine, inflammation, and neurodegenerative disorders. Because of the effects on NO levels and known inhibitors to DDAH, regulation of DDAH may be an effective way to regulate NO levels therefore treating the diseases. | ||
| - | |||
| - | == Structural highlights == | ||
| - | |||
| - | ==Inhibitors== | ||
| - | ===Zinc at pH 6.3=== | ||
| - | ===Zinc at pH 9=== | ||
| - | ===L-citrulline, L-homocysteine, and S-nitroso-L-homocysteine=== | ||
| - | L-homocysteine and L-citrulline bind in the active site in the same orientation to create the same intermolecular bonds between it and DDAH. L-citrulline is a product of DDAH hydrolyzing ADMA and MMA, suggesting DDAH activity creates a negative feedback look on itself. Both molecules enter the active site and cause DDAH to be in its closed lid formation. The αC on either molecule creates three salt bridges with DDAH: two with the guanidine group of Arg144 and one with the guanidine group Arg97. The molecules are stabilized in the active site by H-bonds: αC-amino group of the ligand to main chain carbonyls of Val267 and Leu29. Side chains of Asp78 and Glu77 with the ureido group of L-citrulline | ||
| - | Like L-homocysteine and L-citrulline, S-nitroso-L-homocysteine binds and the lid region of DDAH is closed. When DDAH reacts with S-nitroso-L-homocysteine, a covalent product, N-thiosulfximide exist in the active site. N-thiosulfximide is stabilized by several salt bridges and H-bonds. Arg144 and Arg97 stabilize the αC-carbonyl group via salt bridges, and Leu29, Val267, and Asp72 stabilize the Cα-amino group. | ||
| - | |||
| - | |||
| - | [[Image:P56965_with_homo.gif |300 px|left|thumb|Figure Legend ]] | ||
| - | |||
| - | |||
| - | |||
| - | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
| - | |||
| - | </StructureSection> | ||
| - | == References == | ||
| - | <references/> | ||
Revision as of 01:30, 21 April 2017
Dimethylarginine Dimethylaminohydrolase I Bos Taurus
| |||||||||||
